Verrica PharmaceuticalsVRCA
13F holders, Q1 2026 (March 31)39holders −11
3new positions
15sold out
1famous investor
$5.29avg. 13F price*
At the end of Q1 2026, 39 institutions reported holding Verrica Pharmaceuticals Inc. (VRCA) in their 13F filings, down 11 from Q4 2025. 3 opened new positions and 15 sold out. The largest holders were Caligan Partners LP ($4.9M), Affinity Asset Advisors, LLC ($3.7M) and Cannell Capital LLC ($3.6M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Verrica Pharmaceuticals Inc.
- CUSIP
- 92511W207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $3.7M |
| Exits | 15 | $3.5M |
All 13F filers, Q4 2025 → Q1 2026: 926,758 shares bought and 1,417,132 shares sold, net −490,374 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 39 holders
| Caligan Partners LP | 0.35% | No change | 923,910 | $4.9M |
| Affinity Asset Advisors, LLC | 0.22% | No change | 707,338 | $3.7M |
| Cannell Capital LLC | 2.35% | New | 685,123 | $3.6M |
| Armistice Capital, LLC | 0.09% | Reduce -53.7% | 518,181 | $2.7M |
| Velan Capital Investment Management LP | 1.56% | No change | 471,559 | $2.5M |
| Boothbay Fund Management, LLC | 0.04% | No change | 280,734 | $1.5M |
| Vanguard Capital Management LLC | 0.00% | — | 188,758 | $999K |
| DAFNA Capital Management LLC | 0.19% | Reduce -11.4% | 153,712 | $813K |
| Marshall Wace, LLP | 0.00% | Add +65.0% | 140,497 | $743K |
| Geode Capital Management, LLC | 0.00% | Add +105.3% | 138,917 | $735K |
| Stonepine Capital Management, LLC | 0.46% | Reduce -71.8% | 99,735 | $528K |
| Squarepoint Ops LLC | 0.00% | Add +126.0% | 75,208 | $398K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 65,101 | $344K |
| Two Sigma Investments, LP | 0.00% | Reduce -57.1% | 50,662 | $268K |
| Jane Street Group, LLC | 0.00% | Reduce -51.6% | 49,211 | $260K |
| BlackRock, Inc. | 0.00% | Add +578.1% | 38,553 | $204K |
| Renaissance Technologies | 0.00% | Add +22.6% | 32,360 | $171K |
| Northern Trust Corp. | 0.00% | Add +57.7% | 31,580 | $167K |
| State Street Corp. | 0.00% | Add +23.1% | 28,916 | $153K |
| Mariner, LLC | 0.00% | No change | 24,544 | $130K |
| Morgan Stanley | 0.00% | Add +1.7% | 22,386 | $118K |
| Legacy Trust | 0.02% | No change | 17,234 | $91K |
| Verdad Advisers, LP | 0.07% | New | 12,098 | $64K |
| Beck Mack & Oliver LLC | 0.00% | No change | 12,000 | $63K |
| UBS Group AG | 0.00% | Add +17691.7% | 4,270 | $23K |
| Capital Analysts, LLC | 0.00% | No change | 1,500 | $8K |
| Royal Bank of Canada | 0.00% | Add +132.0% | 965 | $5K |
| Vanguard Global Advisers, LLC | 0.00% | — | 862 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -74.4% | 856 | $5K |
| Salomon & Ludwin, LLC | 0.00% | No change | 290 | $2K |
| New England Capital Financial Advisors LLC | 0.00% | No change | 200 | $1K |
| International Assets Investment Management, LLC | 0.00% | No change | 175 | $961 |
| Fortitude Family Office, LLC | 0.00% | Reduce -79.1% | 127 | $672 |
| BNP Paribas Financial Markets | 0.00% | No change | 110 | $582 |
| PNC Financial Services Group, Inc. | 0.00% | No change | 102 | $540 |
| JPMorgan Chase & Co. | 0.00% | No change | 47 | $224 |
| Optiver Holding B.V. | 0.00% | No change | 31 | $164 |
| Jones Financial Companies LLLP | 0.00% | New | 26 | $114 |
| MAI Capital Management | 0.00% | No change | 2 | $11 |
"% of holder's portfolio" is VRCA's weight in each manager's 13F, not the share of Verrica Pharmaceuticals Inc. the manager owns.